Search research articles
Contact Us
Filters
Showing results (1-10 of 229) with videos related to
Page
of 23
Sort By:
Future Oncology (London, England)
|
May 9, 2015
Molecular pathogenesis of ovarian clear cell carcinoma
Ioannis Gounaris, James D Brenton
Breast Cancer Research : BCR
|
July 1, 2005
Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt
Ahmed Ashour Ahmed, James D Brenton
The Lancet. Oncology
|
July 12, 2011
Evolution of platinum resistance in high-grade serous ovarian cancer
Susanna L Cooke, James D Brenton
Trends in Genetics : TIG
|
August 2, 2016
Sequencing Structural Variants in Cancer for Precision Therapeutics
Geoff Macintyre, Bauke Ylstra, James D Brenton
Thorax
|
September 1, 1996
Ecstasy induced pneumomediastinum
K Rezvani, A S Kurbaan, D Brenton
Cancer Surveys
|
January 1, 1995
Genomic imprinting and cancer
J D Brenton, S Viville, M A Surani
The Journal of Pathology. Clinical Research
|
July 14, 2018
You won't believe this old test … that does cheap single-cell mutation detection
Martin Köbel, Michael S Anglesio, James D Brenton
Molecular Cancer
|
May 30, 2012
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
David A Tumbarello, Jillian Temple, James D Brenton
Breast Cancer Research : BCR
|
March 16, 2001
Molecular profiling of breast cancer: portraits but not physiognomy
J D Brenton, S A Aparicio, C Caldas
Clinical Radiology
|
August 14, 2021
Circulating tumour DNA for clinicians: current and future clinical applications
M K Thompson, D Gale, J D Brenton
Page
of 23
Search research articles
Search
Showing results (1-10 of 229) with videos related to
Sort By:
Page
of 23
Future Oncology (London, England)
|
May 9, 2015
Molecular pathogenesis of ovarian clear cell carcinoma
Ioannis Gounaris, James D Brenton
Breast Cancer Research : BCR
|
July 1, 2005
Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt
Ahmed Ashour Ahmed, James D Brenton
The Lancet. Oncology
|
July 12, 2011
Evolution of platinum resistance in high-grade serous ovarian cancer
Susanna L Cooke, James D Brenton
Trends in Genetics : TIG
|
August 2, 2016
Sequencing Structural Variants in Cancer for Precision Therapeutics
Geoff Macintyre, Bauke Ylstra, James D Brenton
Thorax
|
September 1, 1996
Ecstasy induced pneumomediastinum
K Rezvani, A S Kurbaan, D Brenton
Cancer Surveys
|
January 1, 1995
Genomic imprinting and cancer
J D Brenton, S Viville, M A Surani
The Journal of Pathology. Clinical Research
|
July 14, 2018
You won't believe this old test … that does cheap single-cell mutation detection
Martin Köbel, Michael S Anglesio, James D Brenton
Molecular Cancer
|
May 30, 2012
ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
David A Tumbarello, Jillian Temple, James D Brenton
Breast Cancer Research : BCR
|
March 16, 2001
Molecular profiling of breast cancer: portraits but not physiognomy
J D Brenton, S A Aparicio, C Caldas
Clinical Radiology
|
August 14, 2021
Circulating tumour DNA for clinicians: current and future clinical applications
M K Thompson, D Gale, J D Brenton
Page
of 23